Enlivex
Enlivex is a biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Enlivex Information
Geographic Data
Address: 14 Einstein Street
City: Nes-Ziona
State: center district
Zip: 7403618
Country: IL
Financial Info
Stage:
grant
Raised Last:
$1M
Raised Total:$76M
Social
Metrics
560,006Website Global Rank
80,832Website Monthly Traffic
Twitter Followers
Description
Enlivex is a biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer.
Contact Phone:
Contact Email:
Enlivex went public on 3/27/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
3/27/2019
Ticker Symbol:
ENLV
IPO Price:
$12.25/share
Amount Raised:
$5M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
